Disc Medicine Inc
IRONHealthcare|Biotechnology|USA
$76.59
-2.32 (-2.94%)
Tangible Book
$18.03
Earnings Power
$18.04
Upcoming Data Readouts (2)
Feb 2027
Est. completion
P2Polycythemia Vera (PV)
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
NCT06985147n=60
Jun 2027
Est. completion
P1Sickle Cell Disease
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
NCT07187973n=24
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.